Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Baiyunshan Tianxin Pharmaceutical is a leading Chinese pharmaceutical manufacturer and a core subsidiary of Guangzhou Baiyunshan Pharmaceutical Holdings. Founded in 1948, the company has evolved into one of China's largest production bases for antibiotic injections and cardiovascular drugs. Its product portfolio is anchored by cephalosporin antibiotics and specialized treatments like Alprostadil for injection. The company maintains high-standard GMP manufacturing facilities and is a significant player in the domestic Chinese healthcare market, focusing on high-quality parenteral medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Baiyunshan Tianxin Pharmaceutical.